| Elizabeth Sailhamer Soukup, MD, MMSC | |
|
1 Elliot Way, Manchester, NH 03103-3502 | |
| (603) 663-8393 | |
| (603) 663-3493 |
| Full Name | Elizabeth Sailhamer Soukup |
|---|---|
| Gender | Female |
| Speciality | Surgery - Pediatric Surgery |
| Location | 1 Elliot Way, Manchester, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083720858 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0120X | Surgery - Pediatric Surgery | 16391 (New Hampshire) | Primary |
| Entity Name | Mary Hitchcock Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023092053 PECOS PAC ID: 4486561164 Enrollment ID: O20031126000258 |
News Archive
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, and muscle, today announced preliminary results from the ACE-031 Phase 1 single dose clinical trial demonstrating that ACE-031 increased lean body mass and muscle volume. The results from this randomized, placebo-controlled study were presented at the 14th International Congress of the World Muscle Society in Geneva, Switzerland.
The results of a study conducted by scientists at the University of Turku, Åbo Akademi University, and University of Bristol, show that people who tend to react negatively to rules and recommendations have lower trust in medical doctors and a more negative attitude towards vaccines, or reject vaccines for themselves or their children.
An international research team has identified seven new gene loci linked to obesity. Researchers were also able to show that the genetic mechanisms that cause extreme obesity are similar to those that cause milder forms of overweight and obesity.
September is Muscular Dystrophy Awareness Month. There are more than 100 neuromuscular disorders and it is estimated more than 50,000 Canadians are affected by one form or another. Each form is caused by an error in a specific gene related to muscle function.
Baxter International Inc. commends the Centers for Medicare and Medicaid Services (CMS) on announcing implementation plans for a new Medicare benefit that will provide Stage 4 chronic kidney disease patients with coverage for up to six sessions explaining their treatment options, such as transplantation, home peritoneal dialysis (PD), home hemodialysis (HHD) or clinic-based hemodialysis (HD).
› Verified 5 days ago
| Entity Name | Elliot Professional Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285627935 PECOS PAC ID: 6103727920 Enrollment ID: O20040115000634 |
News Archive
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, and muscle, today announced preliminary results from the ACE-031 Phase 1 single dose clinical trial demonstrating that ACE-031 increased lean body mass and muscle volume. The results from this randomized, placebo-controlled study were presented at the 14th International Congress of the World Muscle Society in Geneva, Switzerland.
The results of a study conducted by scientists at the University of Turku, Åbo Akademi University, and University of Bristol, show that people who tend to react negatively to rules and recommendations have lower trust in medical doctors and a more negative attitude towards vaccines, or reject vaccines for themselves or their children.
An international research team has identified seven new gene loci linked to obesity. Researchers were also able to show that the genetic mechanisms that cause extreme obesity are similar to those that cause milder forms of overweight and obesity.
September is Muscular Dystrophy Awareness Month. There are more than 100 neuromuscular disorders and it is estimated more than 50,000 Canadians are affected by one form or another. Each form is caused by an error in a specific gene related to muscle function.
Baxter International Inc. commends the Centers for Medicare and Medicaid Services (CMS) on announcing implementation plans for a new Medicare benefit that will provide Stage 4 chronic kidney disease patients with coverage for up to six sessions explaining their treatment options, such as transplantation, home peritoneal dialysis (PD), home hemodialysis (HHD) or clinic-based hemodialysis (HD).
› Verified 5 days ago
| Entity Name | Dartmouth-hitchcock Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548210198 PECOS PAC ID: 4183537509 Enrollment ID: O20040809000442 |
News Archive
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, and muscle, today announced preliminary results from the ACE-031 Phase 1 single dose clinical trial demonstrating that ACE-031 increased lean body mass and muscle volume. The results from this randomized, placebo-controlled study were presented at the 14th International Congress of the World Muscle Society in Geneva, Switzerland.
The results of a study conducted by scientists at the University of Turku, Åbo Akademi University, and University of Bristol, show that people who tend to react negatively to rules and recommendations have lower trust in medical doctors and a more negative attitude towards vaccines, or reject vaccines for themselves or their children.
An international research team has identified seven new gene loci linked to obesity. Researchers were also able to show that the genetic mechanisms that cause extreme obesity are similar to those that cause milder forms of overweight and obesity.
September is Muscular Dystrophy Awareness Month. There are more than 100 neuromuscular disorders and it is estimated more than 50,000 Canadians are affected by one form or another. Each form is caused by an error in a specific gene related to muscle function.
Baxter International Inc. commends the Centers for Medicare and Medicaid Services (CMS) on announcing implementation plans for a new Medicare benefit that will provide Stage 4 chronic kidney disease patients with coverage for up to six sessions explaining their treatment options, such as transplantation, home peritoneal dialysis (PD), home hemodialysis (HHD) or clinic-based hemodialysis (HD).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Sailhamer Soukup, MD, MMSC 1 Elliot Way, Manchester, NH 03103-3502 Ph: (603) 663-8393 | Elizabeth Sailhamer Soukup, MD, MMSC 1 Elliot Way, Manchester, NH 03103-3502 Ph: (603) 663-8393 |
News Archive
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, and muscle, today announced preliminary results from the ACE-031 Phase 1 single dose clinical trial demonstrating that ACE-031 increased lean body mass and muscle volume. The results from this randomized, placebo-controlled study were presented at the 14th International Congress of the World Muscle Society in Geneva, Switzerland.
The results of a study conducted by scientists at the University of Turku, Åbo Akademi University, and University of Bristol, show that people who tend to react negatively to rules and recommendations have lower trust in medical doctors and a more negative attitude towards vaccines, or reject vaccines for themselves or their children.
An international research team has identified seven new gene loci linked to obesity. Researchers were also able to show that the genetic mechanisms that cause extreme obesity are similar to those that cause milder forms of overweight and obesity.
September is Muscular Dystrophy Awareness Month. There are more than 100 neuromuscular disorders and it is estimated more than 50,000 Canadians are affected by one form or another. Each form is caused by an error in a specific gene related to muscle function.
Baxter International Inc. commends the Centers for Medicare and Medicaid Services (CMS) on announcing implementation plans for a new Medicare benefit that will provide Stage 4 chronic kidney disease patients with coverage for up to six sessions explaining their treatment options, such as transplantation, home peritoneal dialysis (PD), home hemodialysis (HHD) or clinic-based hemodialysis (HD).
› Verified 5 days ago
Dr. Jeffrey Robert Harnsberger, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 Hitchcock Way, Manchester, NH 03104 Phone: 603-695-2840 Fax: 603-695-2985 | |
Elena K Foster, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 185 Queen City Ave, Manchester, NH 03101 Phone: 603-627-1102 Fax: 603-647-5524 | |
Jessica Niewodowski, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 185 Queen City Ave, Manchester, NH 03101 Phone: 603-627-1102 | |
Kimberly Ann Licciardi, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 764 2nd St, Manchester, NH 03102 Phone: 603-669-3925 | |
Esthia Konstantinos Giakovis-sterling, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 184 Tarrytown Rd, Manchester, NH 03103 Phone: 603-627-1102 Fax: 603-647-5524 | |
Edward P. Dalton, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: Elliot Breast Health Center, 275 Mammoth Road, Suite 1, Manchester, NH 03109 Phone: 603-668-3067 Fax: 603-668-0164 |